Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 19/20 | 0.64 |
| ▸ | PGR | P06401 | 2/20 | 0.47 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.47 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1771767 | 0.83 | AR (0.66) | ARPGRNR3C1NR3C2 | |
| SCHEMBL1772145 | 0.81 | AR (0.68) | ARPGRNR3C1NR3C2 | |
| SCHEMBL1772269 | 0.79 | AR (0.70) | ARPGRNR3C1NR3C2 | |
| SCHEMBL1771354 | 0.78 | AR (1.00) | ARPGRNR3C1NR3C2 | |
| SCHEMBL5513525 | 0.78 | AR (0.63) | ARPGRNR3C1NR3C2 | |
| SCHEMBL1771439 | 0.76 | AR (1.00) | AR | |
| SCHEMBL1770638 | 0.75 | AR (0.67) | AR | |
| SCHEMBL1770828 | 0.74 | AR (1.00) | AR | |
| SCHEMBL1771196 | 0.74 | AR (0.67) | AR | |
| SCHEMBL31331602 | 0.74 | AR (1.00) | AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1181341-B1 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | URAY GEORG (AT) | 2004-10-27 | — | — | EP | disclosed |
| US-6635759-B2 | Used as luminescent marker for peptides, proteins, RNA and DNA, as complexing agent | Uray, Georg (AT) | 2003-10-21 | — | — | US | disclosed |
| US-20020058793-A1 | Luminescent 4-trifluoromethy1-2-quinolones with long wave UV absorption and their use | AGILENT TECHNOLOGIES, INC. | 2002-05-16 | — | — | US | disclosed |
| EP-1181341-A2 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | Uray, Georg (AT) | 2002-02-27 | — | — | EP | disclosed |
| WO-2000066680-A2 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | URAY GEORG (AT) | 2000-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058793-A1 | Luminescent 4-trifluoromethy1-2-quinolones with long wave UV absorption and their use | CYP4F2, CYP4F12, CRY1 | AR 4741/4885PGR 4774/4885NR3C1 3087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.